Physician profile
Ali Dawlatly
NPI 1679918288
$4,564.88
in general payments reported to CMS, 2019-2025
8 companies · $4,107 in 2025
The $4,107 reported for 2025 was more than what 95% of Oral & Maxillofacial Surgery providers received nationally (typical 2025 total: $184).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $92.06 · 2020: $193 · 2022: $28.10 · 2023: $145 · 2025: $4,107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,094 · Travel and Lodging: $2,058 · Gift: $100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,094.06 |
| Travel and Lodging | $2,057.60 |
| Gift | $100.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $3,865.58 | 2020-2025 | |
| Depuy Synthes Sales INC. | $278.79 | 2020-2025 | Matrixmandible, Trumatch |
| Orthofix Medical, INC. | $126.89 | 2023 | Trinity Elite |
| Stryker Corporation | $119.34 | 2025 | Na |
| Geistlich Pharma, North America, INC. | $92.06 | 2019 | |
| Axogen | $34.95 | 2020-2023 | Avance Nerve Graft |
| Dentsply Sirona INC | $28.10 | 2022 | |
| Zimvie INC. | $19.17 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Dawlatly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.